Navigating Oxbryta Recall Claims: How KBA Can Help with Pharmaceutical Product Liability Cases

In a world where pharmaceutical advancements bring life-changing benefits, there’s also the unfortunate reality of risks and recalls. The recent Oxbryta recall has cast a spotlight on the potential dangers of medications designed to help patients with severe medical conditions, such as sickle cell disease.

For affected patients and families, the aftermath of a defective or dangerous drug can be overwhelming. At Ketterer, Browne & Associates, LLC (KBA), our team of experienced pharmaceutical product liability lawyers is here to guide you through this challenging time.

What is Oxbryta?

Oxbryta (voxelotor) is a prescription medication approved by the FDA for treating sickle cell disease (SCD). Global Blood Therapeutics manufacturers Oxbryta. Per FDA, “FDA approved Oxbryta under the accelerated approval pathway in 2019 for the treatment of sickle cell disease in adults and pediatric patients 12 years of age and older. In 2021, FDA granted accelerated approval of Oxbryta for the treatment of sickle cell disease in patients 4 to 11 years of age.”

It increases hemoglobin levels and reduces sickle cell complications. Concerns over safety, contamination, mislabeling, or adverse side effects led to a recall of certain Oxbryta batches.

What Happened with the Oxbryta Recall?

A recall arose from reports of serious Oxbrcyta side effects and potential Oxbrcyta health risks. FDA’s recall notice explains,

“In postmarketing clinical trials of Oxbryta, Pfizer reported a higher rate of vaso-occlusive crisis (severe pain caused by sickled red blood cells blocking blood flow and oxygen delivery to tissues) in patients with sickle cell disease receiving Oxbryta compared to placebo. There were also more deaths in the Oxbryta treatment group as compared to the placebo group in these postmarketing studies. Pfizer also observed a higher rate of vaso-occlusive crisis in patients with sickle cell disease receiving Oxbryta in two real-world registry studies. Based on the totality of clinical data, Pfizer has determined the benefit of Oxbryta does not outweigh the risk.” Put simply, the product is now unavailable.

“Pfizer Inc., the manufacturer of Oxbryta, announced it is voluntarily withdrawing the medication from the market, ceasing distribution, and discontinuing all active clinical trials and expanded access programs for Oxbryta because recent data indicate the benefit of Oxbryta does not outweigh the risks for the sickle cell patient population.”

Thee recall of Oxbrcyta may leave patients grappling with serious health complications, financial burdens, and emotional distress. If you or your loved one has been affected, you may have grounds for a pharmaceutical liability lawsuit.

How KBA’s Pharmaceutical Product Liability Lawyers Can Assist

KBA’s team has a proven track record of holding large pharmaceutical companies accountable for injuries caused by unsafe medications. Here’s how we can help:

1. Comprehensive Case Evaluation

Our attorneys will carefully evaluate your case, reviewing medical records, treatment history, and the circumstances surrounding your use of Oxbryta. This ensures that every detail is captured to build a strong claim.

2. Expert Legal Representation

KBA’s skilled lawyers litigate product liability claims, including:

• Manufacturing Defects: Where a problem occurred during production.
• Design Defects: When the drug’s composition was inherently dangerous.
• Inadequate Warnings: Where risks were not clearly communicated.

3. Pursuing Maximum Compensation

From medical expenses and lost wages to pain and suffering, we fight for full and fair compensation for the damages you’ve experienced.

Why Choose KBA?

At KBA, we believe in more than just legal advocacy—we’re committed to client care. Our firm’s focus on pharmaceutical product liability cases ensures that your claim receives the expertise and attention it deserves. With personalized service, thorough investigation, and aggressive litigation, we stand as your ally against corporate negligence.

What to Do If You Took a Recalled Oxbryta Prescription

1. Check the Recall Notice: Visit the FDA website or contact your pharmacy to verify if your batch is affected.
2. Consult Your Doctor: Do not stop taking Oxbryta without medical advice.
3. Document Your Symptoms: Keep track of side effects, medical visits, and prescriptions.
4. Seek Legal Advice: Contact an experienced drug recall attorney to explore your options.

Contact Our Oxbryta Recall Lawyers Today

If you or a loved one suffered harm due to a recalled Oxbryta batch, you may be eligible for compensation. Time is limited to file a claim, so don’t wait.

Act Now: Protect Your Rights

The window to file a lawsuit in cases like the Oxbryta recall may be limited by state-specific statutes of limitations. Don’t wait until it’s too late. Contact Ketterer, Browne & Associates, LLC today for a free consultation with one of our experienced pharmaceutical product liability lawyers.

Take the first step towards justice. Call 855-KBA-LAWS (522-5297), Contact Us, or email Info@KBAAttorneys.com to schedule your consultation now.

Let KBA fight for you while you focus on healing and moving forward.

Disclaimer: This blog post is for informational purposes only and does not constitute medical or legal advice. Never stop taking a drug based on a lawyer ad/post. Speak with your healthcare prodfessional.